Investmark Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Investmark Advisory Group's ABBV Position: Q3 2026 in Review
Investmark Advisory Group increased its AbbVie (ABBV) stake by 1.1% in Q3 2026, buying an estimated $66.9K and bringing the position to 23,355 shares worth $6.11M. The position accounts for 1.98% of the portfolio, ranked #8.
Investmark Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 4,243 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Investmark Advisory Group held 23,355 shares of AbbVie worth $6.11M as of Q3 2026.
- Investmark Advisory Group bought 261 AbbVie shares in Q3 2026, an estimated $66.9K.
- AbbVie made up 1.98% of Investmark Advisory Group's portfolio in Q3 2026, its #8 holding.
- Investmark Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 4,243 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Investmark Advisory Group's 13F filing for Q3 2026, filed 27 Oct 2026.